$0.68
-0.08 (-10.11%)
Open$0.76
Previous Close$0.75
Day High$0.76
Day Low$0.67
52W High$3.28
52W Low$0.91
Volume—
Avg Volume549.8K
Market Cap401.93M
P/E Ratio—
EPS$-0.63
SectorPharmaceuticals
Analyst Ratings
Buy
12 analysts
Price Target
+3,377.9% upside
Current
$0.68
$0.68
Target
$23.50
$23.50
$17.63
$23.50 avg
$33.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 577.58M | 648.53M | 156.52M |
| Net Income | -533,544,390 | -539,175,781 | 22.40M |
| Profit Margin | -92.4% | -87.8% | 14.3% |
| EBITDA | -317,428,972 | -338,600,408 | 28.04M |
| Free Cash Flow | — | — | 15.05M |
| Rev Growth | -10.9% | -10.9% | +1.7% |
| Debt/Equity | 0.35 | 0.35 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |